Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Atzeni

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Reumatismo|June 19, 2014
Physiopathology of pain in rheumatologyM Cazzola, F Atzeni, L Boccassini, et al.
Clinical and Experimental Rheumatology|March 26, 2005
Thyroid acropachy: an unusual rheumatic manifestation of Graves' diseaseF Capsoni, F Minonzio, P Sarzi-Puttini, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin AF Atzeni, P Sarzi-Puttini, F Capsoni, et al.
Lupus|October 13, 2005
Tumor necrosis factor-alpha, biologic agents and cardiovascular riskP Sarzi-Puttini, F Atzeni, A Doria, et al.
Reumatismo|September 10, 2016
Possible relationship between certolizumab pegol and arrhythmias: report of two casesR Talotta, F Atzeni, A Batticciotto, et al.
Annals of the Rheumatic Diseases|August 5, 2005
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3P Sarzi-Puttini, F Atzeni, J Schölmerich, et al.
European Journal of Endocrinology|October 7, 2000
The usefulness of conventional and echo colour Doppler sonography in the differential diagnosis of toxic multinodular goitresF Boi, M Loy, M Piga, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritisM Benucci, G Saviola, P Baiardi, et al.
Lupus|October 13, 2005
Behçet's disease and cardiovascular involvementF Atzeni, P Sarzi-Puttini, A Doria, et al.
Clinical and Experimental Rheumatology|December 24, 2010
Which kind of exercise is best in fibromyalgia therapeutic programmes? A practical reviewM Cazzola, F Atzeni, F Salaffi, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Reumatismo|June 19, 2014
Physiopathology of pain in rheumatologyM Cazzola, F Atzeni, L Boccassini, et al.
Clinical and Experimental Rheumatology|March 26, 2005
Thyroid acropachy: an unusual rheumatic manifestation of Graves' diseaseF Capsoni, F Minonzio, P Sarzi-Puttini, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin AF Atzeni, P Sarzi-Puttini, F Capsoni, et al.
Lupus|October 13, 2005
Tumor necrosis factor-alpha, biologic agents and cardiovascular riskP Sarzi-Puttini, F Atzeni, A Doria, et al.
Reumatismo|September 10, 2016
Possible relationship between certolizumab pegol and arrhythmias: report of two casesR Talotta, F Atzeni, A Batticciotto, et al.
Annals of the Rheumatic Diseases|August 5, 2005
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3P Sarzi-Puttini, F Atzeni, J Schölmerich, et al.
European Journal of Endocrinology|October 7, 2000
The usefulness of conventional and echo colour Doppler sonography in the differential diagnosis of toxic multinodular goitresF Boi, M Loy, M Piga, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritisM Benucci, G Saviola, P Baiardi, et al.
Lupus|October 13, 2005
Behçet's disease and cardiovascular involvementF Atzeni, P Sarzi-Puttini, A Doria, et al.
Clinical and Experimental Rheumatology|December 24, 2010
Which kind of exercise is best in fibromyalgia therapeutic programmes? A practical reviewM Cazzola, F Atzeni, F Salaffi, et al.
Pageof 11